Log In
Print this Print this

Lysine acetylsalicylate glycine (LASAG)

  Manage Alerts
Collapse Summary General Information
Company Vectura Group plc
DescriptionLASAG delivered using Activaero's FAVORITE inhalation delivery technology
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationInfluenza virus
Indication DetailsTreat influenza infection
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today